Kupando
PrivateLast Round
Series A
Extension
Mar 18, 2026
Total Funding Raised
$11.5M
Company Overview
Kupando is a biotechnology company developing therapies for cancer and infectious diseases. The company's approach is centered on stimulating the innate immune system through dual Toll-Like Receptor (TLR) 4/7 agonists, with its lead candidate being KUP101.
Sector
Enterprise Software
Verticals
Low-Code/No-Code, Marketing, Sales Enablement, Customer Experience
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kupando Comps
Public and private peers based on sector, stage, and business model.
Kupando Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 18, 2026 |
Kupando Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeCare Partners | Series A Extension |
| European Regional Development Fund (Brandenburg) | Series A Extension |
| Remiges Ventures | Series A Extension |
| Brandenburg Kapital | Series A Extension |
| Ventura BioMed Investors | Series A Extension |
| CARMA FUND | Series A Extension |
| High-Tech Gründerfonds | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$11.5M raised in Series A Extension round.
Kupando Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kupando's valuation, stock price, and market status.
